March 12, 2020
UW Innovation Highlighted on Italian TV for Treating Covid-19
Dr. Simone Perazzolo, a scientist in the , was featured on Italian national TV explaining how an FDA approved protease inhibitor called Lopinavir (Kaletra) may be effective against Covid-19 since requires protease enzymes to replicate.
He has highlighted targeted and long-acting drug combinations containing Lopinavir + Tenofovir (HIV and Hepatitis B drugs) currently in late-stage development for human testing by TLC-ART. This therapy聽may potentially replace 30-60 daily pills with a single injection.聽This product candidate was made possible by innovations in drug combination nano-particle technology (DcNP) discovered by the led by Drs. and with the support of the NIH/NIAID, Division of AIDS (DAIDS).
Please follow the video 聽for the full interview.